Bill Snyder Archive — Page 5 of 121

Fluorescence microscopy comparison labeled “Control” and “AD”: bright amyloid oligomer signal follows a retinal vessel in the control panel, while the AD panel shows weaker, more diffuse signal. Scale bar: 20 µm.
April 7, 2026

Multi-institutional team pioneers retinal test for early Alzheimer’s disease

The potential for a retinal screening test was bolstered by a recent discovery that clearance of amyloid-beta oligomers by immune cells in retinal blood vessels was disrupted in donor eyes from individuals with Alzheimer’s disease, compared to age-matched, healthy control eyes.

Illustration comparing normal red blood cells flowing through branching blood vessels with sickle-shaped cells obstructing blood flow. Labels read “Red Blood Cell” and “Sickle Cell Blocking Blood Flow.”
April 7, 2026

Sickle cell disease heightens risk for precancerous blood disorder

These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis.

April 3, 2026

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems,” said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

Blue AAAS graphic with the text “Congrats to the 2025 AAAS Fellows” and a gold medallion near the bottom.
March 26, 2026

Six Vanderbilt faculty named honorary fellows of prestigious scientific society

The 2025 fellows have been invited to the annual AAAS Fellows Forum May 29 in Washington, D.C.

(iStock image)
March 24, 2026

Too much dietary salt linked to new cases of heart failure

Even modest reductions in salt consumption could reduce the burden of heart failure in high-risk populations.

(iStock image)
March 20, 2026

Precancerous blood disorder raises risk of inflammatory heart disease

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.